Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.

In order to assess the potential of interleukin 7 (IL-7) as an immunotherapeutic agent in human melanoma, we have evaluated the in vitro activity of IL-7-induced lymphokine-activated killer (LAK) cells from patients with advanced melanoma against allogeneic and autologous melanoma cells. Peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Böhm, M., Möller, P., Kalbfleisch, U., Worm, M., Czarnetzki, B. M., Schadendorf, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033302/
https://www.ncbi.nlm.nih.gov/pubmed/8018541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033302/
https://www.ncbi.nlm.nih.gov/pubmed/8018541

Ejemplares similares